Facebook held a breakfast to promote ‘clinical trials strategy’

on Sep8

Facebook founder and chief Mark Zuckerberg receives the Axel Springer Award in Berlin on February 25, 2016 Facebook announced it was donating computer servers to a number of research institutions across Europe, starting with Germany, to accelerate research efforts in artificial intelligence (AI) and machine learning.

Kay Nietfeld | AFP | Getty Images

Facebook founder and chief Mark Zuckerberg receives the Axel Springer Award in Berlin on February 25, 2016 Facebook announced it was donating computer servers to a number of research institutions across Europe, starting with Germany, to accelerate research efforts in artificial intelligence (AI) and machine learning.

Facebook’s ad sales team is hitting up the drug industry.

On Thursday, the company’s New York-based health unit hosted an invite-only breakfast for pharmaceutical marketers to learn about targeting users for their clinical trials.

CNBC viewed a copy of the invitation, which asked participants to attend a presentation on the company’s “new clinical trials strategy.”

Facebook is already widely used by clinical trial recruiters, and it’s a massive revenue opportunity for the company. Research firm eMarketer estimates that pharma and health care marketers will spend $3.1 billion on digital advertising by 2020, up from $1.9 billion last year.

According to a person who attended Thursday’s event, Facebook detailed how drug marketers can and can’t target users. The source requested anonymity as Facebook did not make the details public.



Previous postScott Disick opens up his Hidden Hills bachelor pad for lease Next postChina EV venture Future Mobility launches Byton brand, eyes U.S., Europe

Leave a Reply

Your email address will not be published. Required fields are marked *



Los Angeles Financial times


Copyright © 2020 Los Angeles Financial times

Updates via RSS
or Email